Skip to main content
All lobbying clients

TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY)

Lobbying client · District of Columbia · filed 2025 to 2026

Pharmaceutical company.

$480,000 Reported spend
6 Filings counted
1 Firms hired
11 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (127294), not by name.

 Firms hired 1
 Bills named in these filings 11
  • S 1041
    Affordable Prescriptions for Patients Act
    5 filings
  • S 1096
    Preserve Access to Affordable Generics and Biosimilars Act
    5 filings
  • HR 6509
    SAFE Drugs Act of 2025
    3 filings
  • S 1973
    Treat and Reduce Obesity Act of 2025
    3 filings
  • HR 4231
    Treat and Reduce Obesity Act of 2025
    2 filings
  • HR 4818
    Treat and Reduce Obesity Act of 2023
    1 filing
  • HR 6986
    To address patent thickets.
    1 filing
  • S 150
    Affordable Prescriptions for Patients Act of 2023
    1 filing
  • S 2407
    Treat and Reduce Obesity Act of 2023
    1 filing
  • S 3583
    A bill to address patent thickets.
    1 filing
  • S 2658
    Medication Affordability and Patent Integrity Act
    1 filing
 Reported by year 2 years
  • 2026 $160,000 2 filings
  • 2025 $320,000 4 filings
 Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 3
  • Executive Office of the President (EOP) 6
  • HOUSE OF REPRESENTATIVES 6
  • SENATE 6

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem